December 24, 2025
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreDecember 22, 2025
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreDecember 26, 2025
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 238.65 billi...
Read MoreDecember 26, 2025
The simulators market size is forecast to increase from USD 14.72 billion in 2026 to USD 25.53 billion by 2034...
Read MoreOctober 08, 2025
Market insights predict the North America pharmaceutical industry will increase from USD 601.17 billion in 2024 to USD 1043.48 billion by 2034, achieving a CAGR of 5.67%. The continued innovations and high healthcare spending in potential pharmaceutical areas related to diabetes, obesity, oncology, cardiovascular diseases, and neurological disorder...
October 08, 2025
Market insights predict, the Middle East and Africa pharmaceutical industry is expected to grow from USD 75.15 billion in 2024 to USD 141.3 billion by 2034, driven by a CAGR of 6.52%. This market is rising due to increasing chronic disease prevalence, growing healthcare investments, expanding local manufacturing, and improved access through digital...
October 08, 2025
Projections indicate that, APAC cell and gene therapy industry is projected to rise from USD 4.59 billion in 2024 to USD 39.62 billion by 2034, reflecting a CAGR of 24.04% over the next decade. A surge in wider demand for advanced therapies due to rising severe concerns, like cancers, rare disorders, is supporting the overall market growth. China d...
October 08, 2025
Projections indicate that, the APAC biotechnology market will increase from USD 372.23 billion in 2024 to USD 1611.67 billion by 2034, experiencing a CAGR of 14.80% over the next 10 years. The APAC biotechnology market is growing due to rising government initiatives in the region....
October 08, 2025
Projections indicate that, the Middle East and Africa cell and gene therapy market will increase from USD 1.15 billion in 2024 to USD 9.75 billion by 2034, experiencing a CAGR of 23.85% over the next 10 years. The burgeoning biotechnology sector and the growing demand for personalized medicines drive the market....
October 08, 2025
Based on market forecasts, the Europe life science market, projected at USD 26.32 billion in 2024, is expected to reach USD 78.90 billion by 2034, growing at a CAGR of 11.61% over the forecast period. The growing public health concerns, significant scientific advancements, industrial competitiveness, and sustainability initiatives supported the rob...
October 08, 2025
Based on market forecasts, the APAC life science market, projected at USD 17.51 billion in 2024, is expected to reach USD 54.81 billion by 2034, growing at a CAGR of 12.09% over the forecast period. The market is growing due to the rising demand for advanced tools and biopharmaceutical innovations. The Asia Pacific region is dominating with rising ...
October 07, 2025
According to market projections, the Latin America biotechnology market, valued at USD 77.55 billion in 2024, is anticipated to reach USD 277.01 billion by 2034, growing at a CAGR of 13.10% over the next decade. The Latin America biotechnology market is growing due to the presence of diverse biodiversity and increasing healthcare advancements....
October 07, 2025
Market insights predict, the APAC pharmaceutical industry is expected to grow from USD 434.19 billion in 2024 to USD 855.68 billion by 2034, driven by a CAGR of 7.02%. The rising prevalence of chronic disorders and the increasing need for personalized medicines bolster market growth. China’s dominance in the market is attributed to the strong...
October 07, 2025
According to market projections, the specialty medical chairs sector is expected to grow from USD 4.77 billion in 2024 to USD 9.77 billion by 2034, reflecting a CAGR of 7.43%. In 2024, North America led the specialty medical chairs market with a 43% share, while Asia-Pacific is set for strong growth. Rehabilitation chairs dominated, but treatment c...